🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementJoint pain improvement vs new joint pain — a paradox on GLP-1

Joint pain improvement vs new joint pain — a paradox on GLP-1

Dr.RheumBOS Tue, Feb 3, 2026 at 12:22 AM 28 replies 752 viewsPage 1 of 6
Dr.RheumBOS
Member
567
2,345
Apr 2024
Boston, MA
Feb 3, 2026 at 1:47 AM#1

Just had to share this with someone who would understand — joint pain improvement vs new joint.

Got my latest A1C and I am genuinely emotional right now. 12 months in and the progress is real.

Details in the comments but wanted to start this thread because I think others going through the same thing need to see that it works.

49 11pam_stl, wei_SG, cory_ATX and 46 others
Reply Quote Save Share Report
TrialNerd_Beth
Senior Member
2,345
11,234
Jan 2024
Bethesda, MD
Feb 3, 2026 at 2:04 AM#2
Dr.RheumBOS said:
Joint pain improvement vs new joint pain a paradox on GLP-1

I respect Dr.RheumBOS perspective but I think this oversimplifies things a bit. Re: Joint pain improvement vs new — the effect size varies considerably by population.

I am not saying Dr.RheumBOS wrong entirely — just that the picture is more nuanced than a blanket statement. The SURMOUNT data specifically shows baseline BMI-dependent responses.

Last edited: Feb 3, 2026 at 6:04 AM
50 18PharmHunterJen, TomTeleRx, DoseLogDan and 47 others
Reply Quote Save Share Report
kate.chem
VIP Member
3,890
17,654
Dec 2023
California
Feb 3, 2026 at 2:21 AM#3

+1 to Dr.RheumBOS. Especially the point about "Joint pain improvement vs new joint pain..." — I have seen the same in my own experience with Joint pain improvement vs.

39 24tyler_CSCS, VanRx_Mike, steve_okc and 36 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
ingrid_STO
Member
345
1,456
Jul 2024
Stockholm, SE
Feb 3, 2026 at 2:38 AM#4

As a healthcare provider, I want to add some clinical context to this discussion on Joint pain improvement vs new joint pain.

Building on what Dr.RheumBOS said — the evidence base here is well-established. The key publications to reference are from the SURMOUNT program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Feb 3, 2026 at 5:38 AM
47 10InsuranceTom, WendyG_ATL, SaraMom3 and 44 others
Reply Quote Save Share Report
BenResearch_OR
Senior Member
2,456
11,234
Dec 2023
Oregon
Feb 3, 2026 at 2:55 AM#5
kate.chem said:
" — I have seen the same in my own experience with Joint pain improvement vs

Gonna push back on this one. Joint pain improvement vs new joint is not that straightforward in my experience. I have been on this for 18 months and the reality is messier than the trials suggest.

Don't get me wrong — the medication works. But adherence is harder than people admit. We should be honest about that.

46 21PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 43 others
Reply Quote Save Share Report
1236

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register